Clinical Trials
16 trialsNCT07614841 2026-05-29
To Explore the Optimal Therapeutic Window for Imatinib in the Adjuvant Treatment of Intermediate and High-risk Gastrointestinal Stromal Tumors
First Affiliated Hospital, Sun Yat-Sen University
Completed
NCT07171203 2026-05-27
Preoperative Imatinib and Fampridine in KIT Mutant Gastrointestinal Stromal Tumor
University of California, San Diego
Phase 1 Recruiting
NCT07434843 2026-05-22
PEMIGIST
Dana-Farber Cancer Institute
Phase 2 Recruiting
NCT07581977 2026-05-22
A Novel Two-Tooth Clip for ESD and EFTR of GIST
Affiliated Hospital to Academy of Military Medical Sciences
Phase NA Recruiting
NCT02012699 2026-05-05
iCaRe2
University of Nebraska
Recruiting
NCT07550582 2026-04-30
SAVE-GEJ
Peking University People's Hospital
Phase 2 Enrolling by invitation
NCT07559864 2026-04-30
Comparing Regorafenib Combined With Envafolimab to Physician's Choice in Patients With Metastatic Gastrointestinal Stromal Tumors Harboring KIT Exon 17 Mutations Refractory to Standard Treatment
Peking University Cancer Hospital & Institute
Phase 2 Recruiting
NCT05152472 2026-04-24
ATEZOGIST
Centre Leon Berard
Phase 2 Recruiting
NCT07522762 2026-04-13
Long-term Survivorship Challenges of Advanced/Metastatic GIST Patients Responding to Tyrosine Kinase Inhibitor Treatment: an Observational Study
The Netherlands Cancer Institute
Recruiting
NCT05661643 2026-04-07
GIST
Asan Medical Center
Phase 2 Recruiting
NCT05905887 2026-04-07
Rivoceranib Plus Paclitaxel in Patients With Gastrointestinal Stromal Tumor
Asan Medical Center
Phase 2 Recruiting
NCT06326346 2026-04-07
GIST Oral Paclitaxel(Liporaxel)
Asan Medical Center
Phase 2 Recruiting
NCT03944304 2026-04-03
Paclitaxel in Patients With GIST With Low P-glycoprotein Expression After Failure of at Least Imatinib and Sunitinib, and Regorafenib.
Asan Medical Center
Phase 2 Completed
NCT07454967 2026-04-02
Development of a Multimodal AI System for GIST Management
Hebei Medical University
Completed
NCT05500391 2026-03-18
SUR-CAN
Centre Oscar Lambret
Phase 2 Recruiting
NCT01046487 2026-03-13
PALANGI3
Centre Oscar Lambret
Phase 1 Completed